Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Lomme – page 130

1 744 clinical trials in Lomme, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Lomme at a glance
1 744
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 744 trials in Lomme

Open in trial search

Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:Medac Gesellschaft fuer klinische Spezialpraeparate mbH

Study of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Regeneron Pharmaceuticals Inc.

Malignant melanoma

Not recruiting

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Beeline Medicines Corp.

Colitis ulcerative

Not recruiting

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Gilead Sciences Inc.

Follicular lymphoma+2

Not recruiting

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Regeneron Pharmaceuticals Inc.

Malignant melanoma

Not recruiting

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Follicular lymphoma+2

Not recruiting

Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anhydrous Caffeine
  • Sponsor:Kite Pharma Inc.

Study Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Calcium
  • Sponsor:Amgen Inc.

Other cities in France

The busiest research cities in the country

All 366 cities in France

Clinical research in Lomme

What the registry says about research in the country

01 Rheumatology Research

Clinical trials focusing on rheumatoid arthritis and gout management, including innovative treatment approaches and medication optimization studies.

  • JAK inhibitor dose tapering strategies
  • Combination therapy evaluations
  • Gout flare treatments

Multiple studies are investigating novel therapeutic combinations and treatment optimization approaches for chronic inflammatory conditions.

02 Oncology Studies

Innovative research in prostate cancer diagnostics and lymphoma treatments, with emphasis on advanced imaging and combination therapies.

  • Advanced diagnostic imaging
  • Targeted therapy combinations
  • Bladder cancer treatments

These trials aim to improve cancer detection accuracy and treatment efficacy through innovative approaches.

03 Neurology Research

Studies addressing multiple sclerosis, stroke prevention, and Alzheimer's disease through various therapeutic approaches.

  • Cognitive enhancement trials
  • Stroke prevention strategies
  • MS treatment comparisons

Research focuses on both preventive measures and treatment optimization for neurological conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.